Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITDAL@ICU: Vitamin D in Critically Ill Patients
NCT01130181Phase 3Completed
- Start
- May 2010
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Cholecalciferol with Placebo (2 arms). Primary endpoint: Length of hospital stay at 6 months. Started May 2010; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01130181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01130181.